Toward the development of a protein-based group B Streptococcus vaccine.
Cell Rep Med
; 3(2): 100536, 2022 02 15.
Article
in En
| MEDLINE
| ID: mdl-35243427
ABSTRACT
Clinical trials of protein-based vaccines to prevent Group B streptococcal infections are underway. In this issue of Cell Reports Medicine, Pawlowski et al.1 provide an extensive characterization of the immune response generated by the recently tested GBS-NN vaccine.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Streptococcal Infections
/
Streptococcal Vaccines
Limits:
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2022
Document type:
Article